Skip To Main Content

Science at Sanofi

Sort by

Filter

Reset
  • Therapeutical Areas
Thromboprophylaxis in Covid-19 patient by Prof. Carrier. Interactive interview.

Thromboprophylaxis in Covid-19 patient by Prof. Carrier. Interactive interview.

Lp(a) in clinical practice - Risk estimation and how to reduce its associated risk: A European Atherosclerotic Society consensus statement

Lp(a) in clinical practice - Risk estimation and how to reduce its associated risk: A European Atherosclerotic Society consensus statement

Effective and safe dose of enoxaparin for the treatment of cancer associated thrombosis: Subgroup analyses of RIETECAT

Effective and safe dose of enoxaparin for the treatment of cancer associated thrombosis: Subgroup analyses of RIETECAT

Current practice in VTE management in medically ill patients

Current practice in VTE management in medically ill patients

ในงานประชุมวิชาการ โดย บริษัท ซาโนฟี่-อเวนตีส (ประเทศไทย) จำ.กัด ซึ่งจัดขึ้นเมื่อวันที่ 10 พฤษภาคม พ.ศ. 2565 ที่ผ่านมา คณะแพทย์ผู้เชี่ยวชาญร่วมบรรยายผ่านระบบออนไลน์ในประเด็น Current practice in VTE management in medically Ill patients โดยได้รับเกียรติจาก ศ. นพ.พันธุ์เทพ อังชัยสุขศิริ คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล เป็นผู้ดำ.เนินรายการและผู้บรรยาย

Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for world thrombosis day

Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for world thrombosis day

Association of extended anticoagulation therapy with risk of recurrent VTE and bleeding rates in cancer-associated VTE

Association of extended anticoagulation therapy with risk of recurrent VTE and bleeding rates in cancer-associated VTE

Dual antiplatelet therapy for ischemic stroke or transient ischemic attack within 24 hours: More than just a simple combination

Dual antiplatelet therapy for ischemic stroke or transient ischemic attack within 24 hours: More than just a simple combination

Real-world in-hospital antiplatelet-switching strategy after coronary interventions: The SWITCH study

Real-world in-hospital antiplatelet-switching strategy after coronary interventions: The SWITCH study

Risk-stratified thromboprophylaxis in special patient groups

Risk-stratified thromboprophylaxis in special patient groups

Patient centred approach: LUTS & benign prostatic hypertrophy

Patient centred approach: LUTS & benign prostatic hypertrophy

Prof Le Gal's session

Prof Le Gal's session "Thromboprophylaxis in acute medical illness"